| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ciprofloxacin | FAERS: 4 | US FAERS | |
| 2 | Bosentan | FAERS: 2 | US FAERS | |
| 3 | Everolimus | FAERS: 2 | US FAERS | |
| 4 | Octreotide | FAERS: 2 | US FAERS | |
| 5 | Octreotide | FAERS: 2 | US FAERS | |
| 6 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 7 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 8 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 9 | Afatinib | FAERS: 1 | US FAERS | |
| 10 | Aspirin | FAERS: 1 | US FAERS | |
| 11 | Celecoxib | FAERS: 1 | US FAERS | |
| 12 | Clopidogrel | FAERS: 1 | US FAERS | |
| 13 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 14 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 15 | Leuprolide | FAERS: 1 | US FAERS | |
| 16 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 17 | NuvaRing | FAERS: 1 | US FAERS | |
| 18 | Ortho Evra | FAERS: 1 | US FAERS | |
| 19 | PCI 32765 | FAERS: 1 | US FAERS | |
| 20 | Pregabalin | FAERS: 1 | US FAERS | |
| 21 | Sunitinib | FAERS: 1 | US FAERS | |
| 22 | Thyroxine | FAERS: 1 | US FAERS | |
| 23 | Ticagrelor | FAERS: 1 | US FAERS | |
| 24 | apixaban | FAERS: 1 | US FAERS | |
| 25 | etonogestrel | FAERS: 1 | US FAERS | |
| 26 | niraparib | FAERS: 1 | US FAERS | |
| 27 | regorafenib | FAERS: 1 | US FAERS | |
| 28 | testosterone 17 beta-cypionate | FAERS: 1 | US FAERS | |
| 29 | Temozolomide | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.